During the past decade, German Low Grade Study Group (Glsg) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "German Low Grade Study Group (Glsg)" #1 collaborator was "German Low Grade Lymphoma Study Group" with 2 trials as a collaborator, "Lymphoma Study Association" with 2 trials as a collaborator, "HOVON - Dutch Haemato-Oncology Association" with 1 trials as a collaborator and "Nordic Lymphoma Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "German Low Grade Study Group (Glsg)" are "Lymphoma, Mantle-Cell" (2 trials), "Lymphoma, Follicular" (1 trials), "Lymphoma, Intermediate-Grade" (1 trials) and "Lymphoma, Low-Grade" (1 trials). Many other conditions were trialed in "German Low Grade Study Group (Glsg)" in a lesser frequency.

Most popular intervention types in "German Low Grade Study Group (Glsg)" are "Drug" (3 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Prednisone" (2 trials), "Rituximab" (2 trials) and "Vincristine" (2 trials). Other intervention names were less common.

The vast majority of trials in "German Low Grade Study Group (Glsg)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "German Low Grade Study Group (Glsg)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in German Low Grade Study Group (Glsg), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in German Low Grade Study Group (Glsg), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".